Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -19,458 | -7,826 | -1,604 | -29,855 |
| Depreciation Amortization | 716 | 431 | 216 | 860 |
| Other Working Capital | -849 | 6,790 | 3,184 | 25,102 |
| Other Operating Activity | -2,737 | -6,261 | -5,610 | -5,752 |
| Operating Cash Flow | $-22,328 | $-6,866 | $-3,814 | $-9,645 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -195 | -86 | -20 | -1,509 |
| Investing Cash Flow | $-195 | $-86 | $-20 | $-1,509 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 682 | 682 | N/A | N/A |
| Debt Issued | 2,750 | 2,750 | 500 | N/A |
| Common Stock Issued | -120 | N/A | N/A | N/A |
| Common Stock Repurchased | -19 | N/A | N/A | N/A |
| Other Financing Activity | 72,283 | 0 | 0 | 3,995 |
| Financing Cash Flow | $75,576 | $3,432 | $500 | $3,995 |
| Beginning Cash Position | 3,704 | 3,704 | 3,704 | 10,863 |
| End Cash Position | 56,757 | 184 | 370 | 3,704 |
| Net Cash Flow | $53,053 | $-3,520 | $-3,334 | $-7,159 |
| Free Cash Flow | ||||
| Operating Cash Flow | -22,328 | -6,866 | -3,814 | -9,645 |
| Capital Expenditure | -195 | -86 | -20 | N/A |
| Free Cash Flow | -22,523 | -6,952 | -3,834 | -9,645 |